The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex
Open accessAbstract
BACKGROUND: Epilepsy appears in 70-80% of patients with tuberous sclerosis complex, most commonly in the first year of age. Early manifestation of epilepsy is associated with drug-resistant epilepsy and mental retardation in more than 80% of patients. Clinical epileptic seizures are preceded by deterioration of EEG recording thus infants with high risk of epilepsy can be identified. AIMS: We hypothesized that preventative antiepileptic treatment of infants with multifocal activity on EEG might lower the incidence of drug-resistant epilepsy and mental retardation. METHODS: Forty-five infants with early diagnosis of tuberous sclerosis complex were included in the open-label study. They were divided in two groups: standard (n=31) and preventative one (n=14). In standard group the antiepileptic treatment was launched early, but after the onset of seizures. In preventative group medication was commenced when active epileptic discharges were seen on EEG, but before the onset of clinical seizures. Children were followed till the end of 2 years of age. RESULTS: At 24 months of age mental retardation was significantly more frequent and severe in "standard" vs "preventative" group (48% vs 14%; p=0.031; mean IQ score 68.7 vs 92.3; p<0.05). The "preventative" group was characterized by higher ratio of seizure-free patients (93% vs 35%; p=0.004), lower incidence of drug-resistant epilepsy (7% vs 42%; p=0.021) and lower number of patients requiring polytherapy (21% vs 55%; 0.039) than the "standard group. CONCLUSIONS: Preventative antiepileptic treatment of infants with tuberous sclerosis complex and high risk of epilepsy markedly improves their neurodevelopmental outcome and reduces the incidence of drug-resistant seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curatolo, P., Bombardieri, R., & Jozwiak, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61279-9 · Cited by 1,088
Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria
Roach, E. S., Gomez, M. R., & Northrup, H. (1998) · Journal of Child Neurology · doi:10.1177/088307389801301206 · Cited by 1,081
Epidemiology of Tuberous Sclerosis
OSBORNE, J. P., FRYER, A., & WEBB, D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37754.x · Cited by 730
Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challenges
Holmes, G. L., Stafstrom, C. E., & The Tuberous Sclerosis Study Group (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01035.x · Cited by 273
JOINSON, C., O'CALLAGHAN, F. J., OSBORNE, J. P., MARTYN, C., HARRIS, T., & BOLTON, P. F. (2003) · Psychological Medicine · doi:10.1017/s0033291702007092 · Cited by 246
Neuropsychological status at seizure onset in children: Risk factors for early cognitive deficits
Fastenau, P. S., Johnson, C. S., Perkins, S. M., Byars, A. W., deGrauw, T. J., Austin, J. K., & Dunn, D. W. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b23551 · Cited by 228
Aldenkamp, A. P., & Arends, J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.005 · Cited by 223
Managing Epilepsy in Tuberous Sclerosis Complex
Thiele, E. A. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190090801 · Cited by 220
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
Bombardieri, R., Pinci, M., Moavero, R., Cerminara, C., & Curatolo, P. (2010) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2009.03.003 · Cited by 208
Early treatment suppresses the development of spike‐wave epilepsy in a rat model
Blumenfeld, H., Klein, J. P., Schridde, U., Vestal, M., Rice, T., Khera, D. S., Bashyal, C., Giblin, K., Paul‐Laughinghouse, C., Wang, F., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01458.x · Cited by 206
Cited by
Northrup, H., Krueger, D. A., Northrup, H., Krueger, D. A., Roberds, S., Smith, K., Sampson, J., Korf, B., Kwiatkowski, D. J., Mowat, D., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.001 · Cited by 1,502
Self-citationKrueger, D. A., Northrup, H., Northrup, H., Krueger, D. A., Roberds, S., Smith, K., Sampson, J., Korf, B., Kwiatkowski, D. J., Mowat, D., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.002 · Cited by 854
Self-citationHenske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 831
Self-citationNorthrup, H., Aronow, M. E., Bebin, E. M., Bissler, J., Darling, T. N., de Vries, P. J., Frost, M. D., Fuchs, Z., Gosnell, E. S., Gupta, N., et al. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.07.011 · Cited by 736
Self-citationDisentangling the heterogeneity of autism spectrum disorder through genetic findings
Jeste, S. S., & Geschwind, D. H. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.278 · Cited by 644
Neurological and neuropsychiatric aspects of tuberous sclerosis complex
Curatolo, P., Moavero, R., & de Vries, P. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00069-1 · Cited by 600
Cerebral plasticity: windows of opportunity in the developing brain
Ismail, F. Y., Fatemi, A., & Johnston, M. V. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.07.007 · Cited by 572
Everolimus treatment of refractory epilepsy in tuberous sclerosis complex
Krueger, D. A., Wilfong, A. A., Holland‐Bouley, K., Anderson, A. E., Agricola, K., Tudor, C., Mays, M., Lopez, C. M., Kim, M., & Franz, D. N. (2013) · Annals of Neurology · doi:10.1002/ana.23960 · Cited by 389
Tuberous Sclerosis registry to increase disease Awareness (TOSCA): baseline data on 2093 patients
on behalf of TOSCA consortium and TOSCA investigators, Kingswood, J. C., d’Augères, G. B., Belousova, E., Ferreira, J. C., Carter, T., Castellana, R., Cottin, V., Curatolo, P., Dahlin, M., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0553-5 · Cited by 267
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
Kotulska, K., Kwiatkowski, D. J., Curatolo, P., Weschke, B., Riney, K., Jansen, F., Feucht, M., Krsek, P., Nabbout, R., Jansen, A. C., et al. (2021) · Annals of Neurology · doi:10.1002/ana.25956 · Cited by 265
Self-citationIdentification of new epilepsy treatments: Issues in preclinical methodology
Galanopoulou, A. S., Buckmaster, P. S., Staley, K. J., Moshé, S. L., Perucca, E., Engel, J., Löscher, W., Noebels, J. L., Pitkänen, A., Stables, J., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03391.x · Cited by 261
Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations
Curatolo, P., Jóźwiak, S., & Nabbout, R. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.05.004 · Cited by 256
Self-citationManagement of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
Curatolo, P., Nabbout, R., Lagae, L., Aronica, E., Ferreira, J. C., Feucht, M., Hertzberg, C., Jansen, A. C., Jansen, F., Kotulska, K., et al. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.05.006 · Cited by 190
Self-citationO'Callaghan, F. J. K., Edwards, S. W., Alber, F. D., Cortina Borja, M., Hancock, E., Johnson, A. L., Kennedy, C. R., Likeman, M., Lux, A. L., Mackay, M. T., et al. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30244-x · Cited by 167
Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
Krueger, D. A., Sadhwani, A., Byars, A. W., de Vries, P. J., Franz, D. N., Whittemore, V. H., Filip‐Dhima, R., Murray, D., Kapur, K., & Sahin, M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.494 · Cited by 133
Long-term treatment of epilepsy with everolimus in tuberous sclerosis
Krueger, D. A., Wilfong, A. A., Mays, M., Talley, C. M., Agricola, K., Tudor, C., Capal, J., Holland-Bouley, K., & Franz, D. N. (2016) · Neurology · doi:10.1212/wnl.0000000000003400 · Cited by 124
Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
Gupta, A., de Bruyn, G., Tousseyn, S., Krishnan, B., Lagae, L., Agarwal, N., Minnesota Epilepsy Group, Frost, M., Sparagana, S., LaJoie, J., et al. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.12.016 · Cited by 64
MicroRNA‑155 contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR signaling pathway
Duan, W., Chen, Y., & Wang, X. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3711 · Cited by 61
Enright, N., Simonato, M., & Henshall, D. C. (2018) · Epilepsia Open · doi:10.1002/epi4.12275 · Cited by 48
Metadata
- Authors
- Jóźwiak, S., Kotulska, K., Domańska-Pakieła, D., Łojszczyk, B., Syczewska, M., Chmielewski, D., Dunin-Wąsowicz, D., Kmieć, T., Szymkiewicz-Dangel, J., Kornacka, M., Kawalec, W., Kuczyński, D., Borkowska, J., Tomaszek, K., Jurkiewicz, E., & Respondek-Liberska, M.
- Venue
- European Journal of Paediatric Neurology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 15
- Issue
- 5
- Pages
- 424-431
- ISSN
- 1090-3798 (ISSN-L)
- OpenAlex
- W2105558792
- Cited by
- 310
- References
- 23
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.